thinspo

seen from Poland
seen from United States
seen from United Kingdom
seen from Italy

seen from United States

seen from United States

seen from Australia
seen from Germany
seen from United Kingdom

seen from United Kingdom
seen from Ireland

seen from United States

seen from United States
seen from France

seen from Greece
seen from United Kingdom
seen from China

seen from China

seen from Germany

seen from France
thinspo
Hold on
Complimenting weight loss by Arielle Juliette
Teeny tiny counterpoint to the “OMG WHY ARE THEY PUSHING GLP-1s ON US ITS A SOCIETY OBSESSED WITH THINNESS AND KEEPING WOMEN DISTRACTED”:
GLP-1s were originally created to treat diabetes.
Glucagon-like peptide-1 (GLP-1) agonists have emerged as a groundbreaking class of medications for managing type 2 diabetes and associated m
They reduce inflammation in multiple diseases.
Glucagon-like peptide 1 receptor agonists (GLP-1RAs) have emerged as promising therapeutic agents with potent anti-inflammatory properties a
They are currently being tested as a treatment for long covid.
Scripps Research scientists launch new digital clinical trial to test repurposed drug for long COVID symptom relief
And they may prevent recurrence for people with breast cancer.
Early research suggests that popular GLP-1 medicines like Ozempic may help to reduce side effects from chemotherapy and improve treatment ou
(Whatever you personally think about society’s obsession with women’s body weight, thinness, and fatphobia, data shows that for breast cancer specifically, increased body weight is both a risk factor for diagnosis and for recurrence. And since weight gain often happens for people in menopause at the same time that they are at higher risk for initial diagnosis OR as people with hormone positive breast cancer are plunged into menopause, GLP-1s are often considered by survivors as a vital lifesaving tool.)
Two things can be true at the same time.
What did you eat today?
Elaura, série Des Femmes et des fleurs, par Rüdy Waks